(Q48007656)

English

Heterologous prime-boost regimen adenovector 35-circumsporozoite protein vaccine/recombinant Bacillus Calmette-Guérin expressing the Plasmodium falciparum circumsporozoite induces enhanced long-term memory immunity in BALB/c mice

scientific article published on 19 April 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22521849

Heterologous prime-boost regimen adenovector 35-circumsporozoite protein vaccine/recombinant Bacillus Calmette-Guérin expressing the Plasmodium falciparum circumsporozoite induces enhanced long-term memory immunity in BALB/c mice (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22521849

Plasmodium falciparum

0 references

long-term memory

1 reference

based on heuristic

inferred from title

Stefan Kaufmann

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22521849

Marita Troye-Blomberg

8

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22521849

Giampietro Corradin

5

object named as

Giampietro Corradin

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22521849

author name string

Charles Arama

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22521849

Yohannes Assefaw-Redda

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22521849

Ariane Rodriguez

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22521849

Carmen Fernández

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22521849

Stephen T Reece

7

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22521849

language of work or name

0 references

publication date

19 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22521849

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22521849

30

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22521849

27

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22521849

4040-4045

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22521849

Comparative efficacy of pre-erythrocytic whole organism vaccine strategies against the malaria parasite

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Long-lived plasma cells: a mechanism for maintaining persistent antibody production

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Prime-boost vectored malaria vaccines: progress and prospects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

That Was Then But This Is Now: Malaria Research in the Time of an Eradication Agenda

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Immunological correlates of protection for the RTS,S candidate malaria vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Synergistic DNA-MVA prime-boost vaccination regimes for malaria and tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Immunogenicity and protection of a recombinant human adenovirus serotype 35-based malaria vaccine against Plasmodium yoelii in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

The Th1 immune response to Plasmodium falciparum circumsporozoite protein is boosted by adenovirus vectors 35 and 26 with a homologous insert

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Protective CD8 T cells against Plasmodium liver stages: immunobiology of an 'unnatural' immune response.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

A synthetic TLR4 agonist formulated in an emulsion enhances humoral and Type 1 cellular immune responses against GMZ2--a GLURP-MSP3 fusion protein malaria vaccine candidate

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Duration of humoral immunity to common viral and vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Humoral immunity and long-lived plasma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Mechanisms that determine plasma cell lifespan and the duration of humoral immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Synthesis and immunological characterization of 104-mer and 102-mer peptides corresponding to the N- and C-terminal regions of the Plasmodium falciparum CS protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Enhanced CD8+ T cell immune responses and protection elicited against Plasmodium berghei malaria by prime boost immunization regimens using a novel attenuated fowlpox virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Prime-boost immunization with adenoviral and modified vaccinia virus Ankara vectors enhances the durability and polyfunctionality of protective malaria CD8+ T-cell responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

CD8+ T effector memory cells protect against liver-stage malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

In-vitro derived germinal centre B cells differentially generate memory B or plasma cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Viral vectors in malaria vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Induction of cross-priming of naive CD8+ T lymphocytes by recombinant bacillus Calmette-Guerin that secretes heat shock protein 70-major membrane protein-II fusion protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

The requirement for potent adjuvants to enhance the immunogenicity and protective efficacy of protein vaccines can be overcome by prior immunization with a recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Clinical assessment of a recombinant simian adenovirus ChAd63: a potent new vaccine vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Interferon-γ: an overview of signals, mechanisms and functions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

T lymphocyte interferon-gamma production induced by Plasmodium falciparum antigen is high in recently infected non-immune and low in immune subjects

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Interferon-gamma responses are associated with resistance to reinfection with Plasmodium falciparum in young African children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

The Plasmodium falciparum-specific human memory B cell compartment expands gradually with repeated malaria infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.04.029

7 January 2021

Identifiers

10.1016/J.VACCINE.2012.04.029

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22521849

release_jhmd7h47kfbv5im4fntk2sw4le

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/22521849

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48007656&oldid=2181323079"